Biocon

In News

Health Canada Approves Biocon Biologics’ YESAFILI as First EYLEA Biosimilar for July 2025 Launch - geneonline.com

geneonline.com - Jul 09, 2025

Lupin, Biocon Leading Gains Amid Trumps Threats Of 200% Tariff On Drug Import - NDTV Profit

NDTV Profit - Jul 09, 2025

From Laurus Labs, Lupin to Biocon— Pharma stocks rise up to 3% despite Trump's 200% tariff threat - Mint

Mint - Jul 09, 2025

Amgen asserts swathes of patents against Biocon, Henlius and Hikma in latest biosimilar spats - IAM Patent

IAM Patent - Jul 01, 2025

Biocon shares gain; stock among top gainers on Nifty Midcap 150 - TradingView

TradingView - Jul 09, 2025

Biocon Biologics wins MHRA UK approval for denosumab biosimilars - The Pharma Letter

The Pharma Letter - Jul 07, 2025

Advancing Bone Health: European Commission Approves Biocon Biologics' Denosumab Biosimilars - PR Newswire

PR Newswire - Jul 03, 2025

Decision on merger with Biocon Biologics soon, says Siddharth Mittal - Business Standard

Business Standard - Jun 23, 2025

Pharma Stocks Rally Despite Trump’s 200% Tariff Threat; Lupin, Biocon Top Gainers - News18

News18 - Jul 09, 2025

Biocon Biologics receives EC approval for Denosumab biosimilars - World Pharmaceutical Frontiers

World Pharmaceutical Frontiers - Jul 04, 2025

Apotex Follows Biocon With Canadian Biosimilar Aflibercept Launch - insights.citeline.com

insights.citeline.com - Jul 07, 2025

Biocon shares gain; stock among top gainers on Nifty Midcap 150 - Moneycontrol

Moneycontrol - Jul 09, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.